Literature DB >> 7125633

Susceptibility of Legionella spp. to mycinamicin I and II and other macrolide antibiotics: effects of media composition and origin of organisms.

P H Edelstein, K A Pasiecznik, V K Yasui, R D Meyer.   

Abstract

Thirty-three strains of Legionella spp., 29 of which were L. pneumophila, were tested for their susceptibilities to erythromycin (EM), rosaramicin, tylosin, mycinamicin I (Sch-27897), and mycinamicin II (Sch-27896). Testing was performed using an agar dilution method with two different types of media: buffered charcoal yeast extract medium supplemented with 0.1% alpha-ketoglutarate (BCYE alpha) and filter-sterilized yeast extract medium with 0.1% alpha-ketoglutarate (BYE alpha). The minimal inhibitory concentrations (MICs) of the drugs tested relative to the MICs of erythromycin were: rosaramicin, MIC approximately equal to 0.2 EM MIC; tylosin, MIC approximately equal to 2 EM MIC; mycinamicin I, MIC approximately equal to 0.5 EM MIC; and mycinamicin II, MIC approximately equal to EM MIC. Both types of media caused equivalent partial inactivation of the macrolides which was apparently due entirely to pH effect. MICs on BCYE alpha were one to five times more than those observed on BYE alpha; this may be due to poorer growth on BYE alpha.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125633      PMCID: PMC183679          DOI: 10.1128/AAC.22.1.90

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

Authors:  L D Sabath; D A Gerstein; P B Loder; M Finland
Journal:  J Lab Clin Med       Date:  1968-12

2.  The rickettsia-like organisms TATLOCK (1943) and HEBA (1959): bacteria phenotypically similar to but genetically distinct from Legionella pneumophila and the WIGA bacterium.

Authors:  G A Hébert; C W Moss; L K McDougal; F M Bozeman; R M McKinney; D J Brenner
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

3.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

4.  Mycinamicins, new macrolide antibiotics. I. Taxonomy, production, isolation, characterization and properties.

Authors:  S Satoi; N Muto; M Hayashi; T Fujii; M Otani
Journal:  J Antibiot (Tokyo)       Date:  1980-04       Impact factor: 2.649

5.  In vitro activity of antimicrobial agents on Legionnaires disease bacterium.

Authors:  C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  Liquid medium for growth of Legionella pneumophila.

Authors:  J D Ristroph; K W Hedlund; R G Allen
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

7.  Susceptibility of Legionella pneumophila to twenty antimicrobial agents.

Authors:  P H Edelstein; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

8.  Antibiotic treatment of guinea-pigs infected with agent of Legionnaires' disease.

Authors:  D W Fraser; I Wachsmuth; C Bopp; J C Feeley; T F Tsai
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

9.  Legionella longbeachae species nova, another etiologic agent of human pneumonia.

Authors:  R M McKinney; R K Porschen; P H Edelstein; M L Bissett; P P Harris; S P Bondell; A G Steigerwalt; R E Weaver; M E Ein; D S Lindquist; R S Kops; D J Brenner
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

Review 10.  Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

View more
  7 in total

1.  In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results.

Authors:  M T García; C Pelaz; M J Giménez; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

2.  Factors influencing the reactivity of Legionella antigens in immunofluorescence tests.

Authors:  R F Benson; G B Malcolm; L Pine; W K Harrell
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

3.  WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.

Authors:  A Saito; K Sawatari; Y Fukuda; M Nagasawa; H Koga; A Tomonaga; H Nakazato; K Fujita; Y Shigeno; Y Suzuyama
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

5.  Isolation and preliminary characterization of erythromycin-resistant variants of Legionella micdadei and Legionella pneumophila.

Authors:  J N Dowling; D A McDevitt; A W Pasculle
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

6.  Pseudomonas mesophilica infections in humans.

Authors:  S M Smith; R H Eng; C Forrester
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

7.  In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.

Authors:  S Floyd-Reising; J A Hindler; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.